Abstract
Purpose
Ferroptosis is a type of regulatory cell death, caused by excessive lipid peroxidation This study aimed to explore whether ionizing radiation could induce ferroptosis in glioma cells and whether carbonic anhydrase 9 (CA9) knockdown could enhance the killing effect of ionizing radiation on hypoxic glioma cells through ferroptosis.
Materials and methods
The protein levels of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) were detected by Western blot in glioma cells irradiated by different doses of X-ray. The relative mRNA levels of ferroptosis markers and intracellular iron-associated proteins were detected by Real-time qPCR. Lipid peroxidation of glioma cells was detected by oxidation-sensitive probe C11-BODIPY581/591 staining. CCK-8 Assay was used to detect cell viability after X-ray irradiation. Cloning formation assay was used to assess the radiosensitivity of glioma cells. The exposure of cell surface calreticulin was measured by immunofluorescence staining.
Results
X-ray induced lipid peroxidation and ferroptosis markers expression in U251 and GL261 glioma cells. Knockdown of CA9 in hypoxic glioma cells significantly altered the expression of iron regulation-related proteins and enhanced X-ray-induced ferroptosis and radiosensitivity. The ferroptosis inhibitor significantly improved the survival of cells irradiated by X-ray, while ferroptosis inducers (FINs) enhanced the lethal effect of X-ray on cells. Enhancing ferroptosis in glioma cells promoted the exposure and release of damage-associated molecular patterns (DAMPs).
Conclusions
Ionizing radiation can induce ferroptosis in glioma cells. CA9 knockdown can enhance the radiosensitivity of hypoxic glioma cells and overcome the resistance of ferroptosis under hypoxia. Enhancing ferroptosis will become a new idea to improve the efficacy of radiotherapy for glioma.
Acknowledgments
The authors thank Yanyan Li for technical assistance.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
Notes on contributors
Wenpeng Huang
Wenpeng Huang is a Master student at the Department of Radiation Biology, Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
Yuping He
Yuping He is a Master student at the Department of Radiation Biology, Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
Shuangyu Yang
Shuangyu Yang is a Master student at the Department of Radiation Biology, Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
Xuefei Xue
Xuefei Xue is a Master student at the Department of Radiation Biology, Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
Hualong Qin
Hualong Qin is a Senior Scientist of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Ting Sun
Ting Sun, PhD, is a Senior Scientist of Neuro-Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Wei Yang
Wei Yang, PhD, is a Professor of Radiation Biology, Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.